Related Experiment Video
Updated: Jan 7, 2026
Mixed Reality Assisted Radical Endoscopic Thyroidectomy
Published on: January 31, 2025
Levothyroxine dose prediction post-thyroidectomy for differentiated thyroid carcinoma
1Department of Endocrinology, Fujian Institute of Endocrinology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Objective:
To address the overestimation of levothyroxine (L-T4) doses in conventional weight-based regimens for individuals who are overweight and obese, this study aimed to identify the most predictive body weight metrics and establish an optimized dosing model for accurate thyroid-stimulating hormone (TSH) suppression following total thyroidectomy in differentiated thyroid carcinoma (DTC).
Methods:
This retrospective study included 385 patients with DTC treated at our institution between October 2019 and December 2024. Patients were stratified by TSH targets (A1: <0.1 mIU/L; A2: 0.1-0.5 mIU/L; A3: 0.5-2.0 mIU/L) and body mass index (BMI) according to Chinese criteria (normal: <24 kg/m²; overweight: 24-27.9 kg/m²; obesity: ≥28 kg/m²). Linear regression analysis was used to analyze correlations between the final stable L-T4 dose and weight metrics, including total body weight, adjusted body weight, lean body weight, ideal body weight, and body surface area, followed by model validation. Model performance was internally validated using a hold-out method. Efficacy was estimated as the accuracy of the model-predicted dose compared with the actual dose required when a patient first achieved their TSH target within the first postoperative year.
Results:
The baseline characteristics showed no significant intergroup differences (P>0.05). Postoperative TSH levels varied significantly according to BMI (P<0.05). Patients with higher BMI required higher total L-T4 doses (µg/d) (P<0.001) but lower weight-adjusted doses (µg/kg/d) (P<0.001). Adjusted body weight best predicted L-T4 dose for patients with BMI ≤ 23.9 kg/m2, while lean body weight was optimal for those with BMI≥24.0 kg/m2. The new model achieved a significantly higher rate of accurate initial dose prediction compared with that via empirical dosing (68.0% vs. 30.2%, P<0.001).
Conclusion:
The BMI-stratified L-T4 dosing formula based on optimized body weight metrics demonstrated improved accuracy, expediting TSH suppression and reducing adverse events.
Related Concept Videos
01:20Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
01:23The Thyroid Gland
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
01:11Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:16Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:18Functions of Thyroid Hormones
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
01:21Drug Dosing: Obese Patients